NCT04907227 2024-07-12
KEYNOTE-921
Merck Sharp & Dohme LLC
Phase 3 Terminated
Merck Sharp & Dohme LLC
Oncopeptides AB
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute